EQNRX
Price
$22.36
Change
+$0.18 (+0.81%)
Updated
Jun 26 closing price
Net Assets
639.71M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

EQNRX vs RMEBX

Header iconEQNRX vs RMEBX Comparison
Open Charts EQNRX vs RMEBXBanner chart's image
MFS Equity Income R1
Price$22.36
Change+$0.18 (+0.81%)
VolumeN/A
Net Assets639.71M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
EQNRX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQNRX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNRX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. EQNRX (640M). EQNRX pays higher dividends than RMEBX: EQNRX (1.26) vs RMEBX (1.16). EQNRX was incepted earlier than RMEBX: EQNRX (13 years) vs RMEBX (11 years). EQNRX (1.70) is less costly to investors than RMEBX (1.07). EQNRX is a more actively managed with annual turnover of: 45.00 vs. RMEBX (31.00). EQNRX has a lower initial minimum investment than RMEBX: EQNRX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. EQNRX (3.92). RMEBX (62.71) and EQNRX (61.42) have equivalent 5 years return.
EQNRXRMEBXEQNRX / RMEBX
Total Expense Ratio1.641.07153%
Annual Report Gross Expense Ratio1.701.07159%
Fund Existence13 years11 years-
Gain YTD5.5897.31576%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets640M106B1%
Annual Yield % from dividends1.261.16108%
Returns for 1 year3.929.5041%
Returns for 3 years28.1625.88109%
Returns for 5 years61.4262.7198%
Returns for 10 years83.5074.51112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp